The often-proposed differentiation of patients with nasal polyps into non-allergic individuals with elevated blood eosinophils for choosing anti-IL-5 therapy, and allergic patients for anti-IgE treatment, is not supported by evidence. The gene discussed is IGHE; the disease is Nasal polyposis.